Amelot Holdings Removes Andrew L. Schwab as Corporate Secretary and Proceeds Against Fitzsimmons Systems With New Counsel
20 Agosto 2010 - 1:44PM
Marketwired
Amelot Holdings, Inc. (PINKSHEETS: AMHD) announced today that it
has removed Andrew L. Schwab as its Corporate Secretary. According
to the company, without any notice, Mr. Schwab vacated his offices,
disconnected his office telephone, fax and personal cell, took down
his website, and left no forwarding address with the U. S. Post
Office.
Amelot Holdings has filed a formal complaint against Mr. Schwab
with the Departmental Disciplinary Committee, Supreme Court,
Appellate Division, in New York City, asking for return of legal
fees paid and payment of other expenses incurred by Amelot as a
result of his actions.
"I regret having to take these actions against Mr. Schwab, but
in the best interest of our Company and its shareholders, I felt it
best to do so," stated Fred Guarnieri, President and CEO.
A lawsuit was filed in the amount of $1,212,500 as Amelot
Holdings, Inc. v. Fitzsimmons Systems, Inc. and Lowell T.
Fitzsimmons, #106102/08. Mr. Schwab had been instructed at a March
2010 meeting to continue prosecution on the Company's behalf of
litigation against Fitzsimmons Systems, Inc. of Syracuse, New York.
Amelot is now working with new counsel to reactivate the lawsuit
and move forward aggressively against Fitzsimmons.
The current outstanding common shares balance is 4,309,573,155
and the number of authorized shares is 4,925,000,000. Mr. Guarnieri
currently owns 736,275,000 shares of the Company's common stock.
There have been no issuances of additional shares since August
2008.
About Amelot Holdings, Inc. (PINKSHEETS: AMHD):
Amelot Holdings, Inc. (http://www.amelotholdings.com), a
publicly traded company, is a diversified holding company that has
identified Biodiesel as a multi-billion emerging Biofuel market.
Amelot plans to have a significant market share in growing low cost
feedstocks to supply the growing demand for biodiesel, to reduce
energy dependency of fossil fuels, to help reduce the U.S.
dependency on foreign oil supplies and reduce the impact of energy
on our environment.
Statements in this press release that are not historical facts
are forward-looking statements within the meaning of the Securities
Act of 1933, as amended. Those statements include statements
regarding the intent, belief or current expectations of the Company
and its management. Such statements reflect management's current
views, are based on certain assumptions and involve risks and
uncertainties. Actual results, events, or performance may differ
materially from the above forward-looking statements due to a
number of important factors, and will be dependent upon a variety
of factors, including, but not limited to, our ability to obtain
additional financing and access funds from our existing financing
arrangements that will allow us to continue our current and future
operations and whether demand for our products and services in
domestic and international markets will continue to expand. The
Company undertakes no obligation to publicly update these
forward-looking statements to reflect events or circumstances that
occur after the date hereof or to reflect any change in the
Company's expectations with regard to these forward-looking
statements or the occurrence of unanticipated events.
Contact: Amelot Holdings, Inc. 1(866)-669-8373
support@amelotholdings.com http://www.amelotholdings.com
HLK Biotech (CE) (USOTC:AMHD)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
HLK Biotech (CE) (USOTC:AMHD)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024